New cervical cancer screening straterg: Combined pap and HPV testing

被引：2
|
作者：
Jin, XW
Zanotti, K
Yen-Lieberman, B
机构：
[1] Cleveland Clin Fdn, Dept Gen Internal Med, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Obstet & Gynecol, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2005年 / 72卷 / 02期
关键词：
D O I：
10.3949/ccjm.72.2.141
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Our strategy for cervical cancer screeing is being revolutionized by our new understanding of how human papillomavirus (HPV) contributes to carcinogenesis and the natural history of cervical cancer. The American Cancer Society and the American College of Obstetricians and Gynecologists now recommend combined HPV and Papanicolaou (Pap) testing for cervical cancer screening in women age 30 or older. However, although incorporation of HPV/DNA testing into primary screening provides clear benefits, it also raises new questions.
引用
收藏
页码：141 / 148
页数：8
相关论文
共 50 条
  • [1] Cervical cancer, Pap smear and HPV testing: An update of the role of organized Pap smear screening and HPV testing
    Sigurdsson, K
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1999, 78 (06) : 467 - 477
  • [2] A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA
    Hogarth, Stuart
    Hopkins, Michael M.
    Rodriguez, Victor
    SOCIOLOGY OF HEALTH & ILLNESS, 2012, 34 (02) : 234 - 250
  • [3] Performance of combined techniques in cervical cancer screening: A comparison of PAP test with HPV DNA testing and cervicography in 1000 patients
    Costa, S
    Sideri, M
    Cristiani, P
    Finarelli, AC
    Naldoni, C
    Terzano, P
    De Nuzzo, M
    Bovicelli, A
    EUROGIN 2000: 4TH INTERNATIONAL MULTIDISCIPLINARY CONGRESS, 2000, : 31 - 37
  • [4] Combined HPV and Pap testing is a potentially beneficial screening approach
    Nature Clinical Practice Oncology, 2008, 5 (2): : 67 - 67
  • [5] Combined Pap and HPV testing in primary screening for cervical abnormalities: Should HPV detection be delayed until age 35?
    Baay, MFD
    Tjalma, WAA
    Larnbrechts, HAJ
    Pattyn, GGO
    Lardon, F
    Weyler, J
    Van Royen, P
    Van Marck, EAE
    Vermorken, JB
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (17) : 2704 - 2708
  • [6] Combined Pap and HPV testing in primary screening for cervical abnormalities: Should HPV detection be delayed until age 35?
    Baay, Marc F. D.
    Tjalma, Wiebren A. A.
    Lambrechts, Hilde A. J.
    Pattyn, Greet G. O.
    Lardon, Filip
    Weyler, Joost
    Van Royen, Paul
    Van Marck, Eric A. E.
    Vermorken, Jan B.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 92 - 92
  • [7] HPV testing for cervical cancer screening: Time for a new paradigm
    Lata, Kusum
    Bhatla, Neerja
    NATIONAL MEDICAL JOURNAL OF INDIA, 2014, 27 (04): : 212 - 213
  • [8] New standard of care—HPV testing for cervical cancer screening
    Philip E. Castle
    Nature Reviews Clinical Oncology, 2015, 12 : 194 - 196
  • [9] Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer
    Costa, S
    Sideri, M
    Syrjänen, K
    Terzano, P
    De Nuzzo, M
    De Simone, P
    Cristiani, P
    Finarelli, AC
    Bovicelli, A
    Zamparelli, A
    Bovicelli, L
    ACTA CYTOLOGICA, 2000, 44 (03) : 310 - 318
  • [10] Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening
    MacLaughlin, Kathy L.
    Jacobson, Robert M.
    Breitkopf, Carmen Radecki
    Wilson, Patrick M.
    Jacobson, Debra J.
    Fan, Chun
    St Sauver, Jennifer L.
    Rutten, Lila J. Finney
    JOURNAL OF WOMENS HEALTH, 2019, 28 (02) : 244 - 249
12345